Valerie Denise Start

Title: Valerie Denise Start: Innovator in Pharmaceutical Compositions

Introduction

Valerie Denise Start is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and dosage forms that are beneficial in cancer treatment. With a total of 2 patents, her work is paving the way for advancements in medical therapies.

Latest Patents

Valerie's latest patents focus on pharmaceutical compositions and dosage forms that include N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino) benzamide. These compositions are designed to be useful in treating subjects with cancer. The disclosures also encompass methods for preparing these pharmaceutical compositions and dosage forms, as well as methods for treating cancer patients using these innovative formulations.

Career Highlights

Valerie is currently associated with Ignyta, Inc., where she continues to contribute her expertise in pharmaceutical innovations. Her work is characterized by a commitment to improving treatment options for cancer patients through her inventive approaches.

Collaborations

Some of her notable coworkers include Daniel Codallos, Jr. and Robert L. Orr, who collaborate with her in advancing the company's mission in the pharmaceutical sector.

Conclusion

Valerie Denise Start is a dedicated inventor whose work in pharmaceutical compositions is making a significant impact in cancer treatment. Her innovative contributions and collaborations are essential in the ongoing fight against this disease.